drugset / Trial / NCT01928485

Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer

NCT01928485

Phase 2 Terminated 6 enrolled Sanjay Gupta PhD
RandomizedParallel-groupOpen-labelTreatment

Summary

This randomized phase II trial studies how well green tea extract works in treating patients with low-risk prostate cancer. Green tea extract contains ingredients that may prevent or slow the growth of certain cancers.

Timeline

Start
2013-08-30
Primary completion
2016-10-05
Completion
2016-11-07

Drugs

EvaluationDrugModalityDoseRoute
Subject green tea extract Unknown Oral

Indications